Yahoo Finance Results
Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2025: Emerging APAC Market & High Unmet NeedsPR Newswire via Yahoo FinanceOct 03 18:15 PM
DUBLIN , October 3, 2017 /PRNewswire/ -- The "Global Chronic Idiopathic Constipation (CIC) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive ...
- GlobeNewswire via Yahoo FinanceOct 10 10:10 AM
TEL-AVIV, Israel and RALEIGH, N.C., Oct. 10, 2017-- RedHill Biopharma Ltd., a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, ...
- GlobeNewswire via Yahoo FinanceOct 20 11:00 AM
RedHill to benefit from various incentives to develop MESUPRON for the adjuvant treatment of pancreatic cancer, including a seven-year marketing exclusivity period for the indication, if approved MESUPRON ...
RedHill Biopharma Announces Poster Presentation at the 2017 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics ConferenceGlobeNewswire via Yahoo FinanceOct 19 12:00 PM
TEL-AVIV, Israel and RALEIGH, N.C., Oct. 19, 2017-- RedHill Biopharma Ltd., a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, ...
Salix Pharmaceuticals Ltd. financial and business news, updates, and information from The New York Times and other leading providers.
View detailed financial information, real-time news, videos, quotes and analysis on Salix Pharmaceuticals Ltd (NASDAQ:SLXP). Explore commentary on Salix ...
Salix Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 19 drugs in the U.S.
Valeant will pay $11.1 billion to acquire Salix Pharmaceuticals' stomach disorders medicines.
Get detailed financial information on Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) including real-time stock quotes, historical charts & financial news, all for free!
- related to Salix Pharmaceuticals Ltd